Patents Assigned to GELPELL AG
  • Oral solid cannabinoid formulations, methods for producing and using thereof
    Patent number: 11654111
    Abstract: Provided are solid oral/per os formulations that include a single cannabinoid, combination of cannabinoids, cannabis extract and combination of cannabis plant constituents. Also provided are methods of making the formulations, as well as therapeutic applications in the treatment and alleviation of various human disorders and/or conditions.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: May 23, 2023
    Assignees: SATIPHARM AG, GELPELL AG
    Inventors: Hagit Sacks, Tomas Edvinsson
  • ORAL SOLID CANNABINOID FORMULATIONS, METHODS FOR PRODUCING AND USING THEREOF
    Publication number: 20200121606
    Abstract: Provided are solid oral/per os formulations that include a single cannabinoid, combination of cannabinoids, cannabis extract and combination of cannabis plant constituents. Also provided are methods of making the formulations, as well as therapeutic applications in the treatment and alleviation of various human disorders and/or conditions.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 23, 2020
    Applicants: GELPELL AG, SATIPHARM AG
    Inventors: Hagit SACKS, Tomas EDVINSSON
  • Oral solid cannabinoid formulations, methods for producing and using thereof
    Patent number: 10555906
    Abstract: Provided are solid oral/per os formulations that include a single cannabinoid, combination of cannabinoids, cannabis extract and combination of cannabis plant constituents. Also provided are methods of making the formulations, as well as therapeutic applications in the treatment and alleviation of various human disorders and/or conditions.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: February 11, 2020
    Assignees: GELPELL AG, SATIPHARM AG
    Inventors: Hagit Sacks, Tomas Edvinsson
  • ORAL SOLID CANNABINOID FORMULATIONS, METHODS FOR PRODUCING AND USING THEREOF
    Publication number: 20180078504
    Abstract: Provided are solid oral/per os formulations that include a single cannabinoid, combination of cannabinoids, cannabis extract and combination of cannabis plant constituents. Also provided are methods of making the formulations, as well as therapeutic applications in the treatment and alleviation of various human disorders and/or conditions.
    Type: Application
    Filed: February 9, 2017
    Publication date: March 22, 2018
    Applicants: GELPELL AG, SATIPHARM AG
    Inventors: Hagit SACKS, Tomas EDVINSSON